Apogee Therapeutics, Inc.（APGE）價格預測APGEApogee Therapeutics, Inc.

Alphio's APGE stock price prediction model matches the current Apogee Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $134.46 (-0.46%). The 1-week path is $134.51 (-0.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Apogee Therapeutics Inc (APGE) is currently trading at $134.97, which is very close to the analyst price target of $135. This indicates that the stock is fairly valued at this moment. The RSI is at 82.663, suggesting that the stock is overbought, which could lead to a price correction. Additionally, the company has reported significant net income losses, with the latest quarter showing a net loss of $85,854,000. The acquisition by AbbVie for $10.9 billion could provide long-term growth potential, but the immediate financial health appears strained due to ongoing losses and high debt obligations. The main risk is the potential dilution of earnings per share by $0.14 as a result of the acquisition financing, which could impact short-term investor sentiment.

Apogee Therapeutics, Inc. (APGE) last closed at $135.08, gaining +0.00%. These facts feed the 1-day and 1-week APGE price prediction above.